Predictive and prognostic value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin

被引：1
|
作者：
Wang, R-X [1 ]
Chen, S. [1 ]
Jin, X. [1 ]
Shao, Z-M [1 ]
机构：
[1] Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P5-16-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-16-13
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Kim, Taeryung
    Han, Wonshik
    Kim, Min Kyoon
    Lee, Jun Woo
    Kim, Jisun
    Ahn, Soo Kyung
    Lee, Han-Byoel
    Moon, Hyeong-Gon
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Im, Seock-Ah
    Park, In Ae
    Kim, Ju-Yeon
    Noh, Dong-Young
    JOURNAL OF BREAST CANCER, 2015, 18 (01) : 16 - 21
  • [22] Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis
    Landry, Kara K.
    Lyon, Jessica L.
    Victoria, Kitty E.
    Changizzadeh, P. Nick
    Cole, Bernard F.
    Pulluri, Bhargavi
    Sikov, William M.
    Wood, Marie E.
    BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 63 - 70
  • [23] The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
    Chen, Xianyu
    He, Chao
    Han, Dongdong
    Zhou, Meirong
    Wang, Quan
    Tian, Jinhui
    Li, Lun
    Xu, Feng
    Zhou, Enxiang
    Yang, Kehu
    FUTURE ONCOLOGY, 2017, 13 (09) : 843 - 857
  • [24] Neoadjuvant bevacizumab with weekly nab-paclitaxel plus carboplatin followed by doxorubicin plus cyclophosphamide (AC) for triple-negative breast cancer
    Snider, Jessica N.
    Young, Robyn R.
    Schwartzberg, Lee Steven
    Allen, Jeffrey Warren
    Javed, Yasir Ahmed
    Jahanzeb, Mohammad
    Sachdev, Jasgit C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)
    Gigolaeva, L.
    Krivorotko, P.
    Khadzhimatova, S.
    Zhiltsova, E.
    Yerechshenko, S.
    Nikitina, M.
    Ni, V.
    Emelyanov, A.
    Imyanitov, E. N.
    Sokolenko, A. P.
    Tabagua, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer
    Zhang, Guojing
    Shi, Zhongyi
    Liu, Lina
    Yuan, Heqing
    Pan, Zheng
    Li, Wenxu
    Tao, Yu
    Huang, Zhaoming
    Huang, Xiaoying
    Lin, Chao
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (02) : 1082 - 1087
  • [27] Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer
    Wu, Long
    Chen, Minyan
    Lin, Yuxiang
    Zeng, Bangwei
    Guo, Wenhui
    Chen, Lili
    Li, Yan
    Yu, Liuwen
    Li, Jing
    Chen, Xiaobin
    Zhang, Wenzhe
    Li, Shengmei
    Cai, Weifeng
    Zhang, Kun
    Jin, Xuan
    Huang, Jianping
    Lin, Qili
    Yang, Yinghong
    Fu, Fangmeng
    Wang, Chuan
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (01) : 27 - 35
  • [28] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Acs, Balazs
    Zambo, Veronika
    Vizkeleti, Laura
    Szazs, A. Marcell
    Madaras, Lilla
    Szentmartoni, Gyongyver
    Tokes, Timea
    Molnar, Bela A.
    Molnar, Istvan Artur
    Vari-Kakas, Stefan
    Kulka, Janina
    Tokes, Anna-Maria
    DIAGNOSTIC PATHOLOGY, 2017, 12 : 1 - 12
  • [29] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Balázs Ács
    Veronika Zámbó
    Laura Vízkeleti
    A. Marcell Szász
    Lilla Madaras
    Gyöngyvér Szentmártoni
    Tímea Tőkés
    Béla Á. Molnár
    István Artúr Molnár
    Stefan Vári-Kakas
    Janina Kulka
    Anna-Mária Tőkés
    Diagnostic Pathology, 12
  • [30] KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance
    Arafah, Maria A.
    Ouban, Abderrahman
    Ameer, Omar Z.
    Quek, Ko Jin
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2021, 15
12345